… pancreatic cancer, the development of chemoresistance still leads to poor clinical outcomes.
Chemoresistance … of the interaction among pancreatic cancer cells, cancer stem cells, and …

… efficacy of current treatments for pancreatic cancer, and in this review, we will summarise the
main mechanisms of chemoresistance in pancreatic cancer with emphasis on the emerging …

… Chemoresistance The majority of studies examining chemoresistance in advanced pancreatic
cancer … It is uncertain why pancreatic cancer cells are more susceptible to gemcitabine …

… cancer cells [25,26,27]. The principles of resistance listed below reflect the complexity of the
mechanisms contributing to chemoresistance … mechanisms underlying chemoresistance in …

… chemoresistance to the current first-line therapy of choice, gemcitabine. There are multiple
factors which contribute to chemoresistance observed in pancreatic cancer. … chemoresistance …

… transition (EMT), cancer stem cells and microRNAs (… pancreatic cancer. We also describe
how this knowledge could be applied to overcoming chemoresistance in pancreatic cancer…

… pancreatic cancer chemoresistance, it is now well established that the immune cells also
impact tumor progression and chemoresistance [… the effect of stellate cells on chemoresistance. …

… stellate cells (PSCs) and their interaction with pancreatic cancer … chemoresistance is
enhanced. This review will discuss how PSCs contribute to chemoresistance in pancreatic cancer. …

… The survival rate for pancreatic cancer is sadly less than 8%. The high fatality rate is partly
… drugs in pancreatic cancer and various factors associated with cancer chemoresistance. …

… chemoresistance. Recent research results suggest potential strategies to overcome gemcitabine
chemoresistance. … of pancreatic cancer growth and dissemination, are now awaited. …